Alexandria Company for Pharmaceuticals and Chemical Industries (AXPH) Key Statistics
26 reported figures for Alexandria Company for Pharmaceuticals and Chemical Industries — valuation multiples, the latest fiscal year's income statement, balance-sheet totals, growth rates and technical readings. Figures with no reported value are omitted rather than shown as zero.
Valuation
- Market cap
- EGP 5.86B
- P/E (trailing)
- 36.43
- P/B
- 5.83
- Dividend yield (FY 2020)
- 1.22%
Income (latest fiscal year)
- Revenue
- EGP 1.02B
- Net income
- EGP 173.83M
- EBITDA
- EGP 248.14M
- Free cash flow
- EGP 77.44M
- Profit margin
- 16.98%
Balance sheet
- Total assets
- EGP 805.28M
- Total debt
- EGP 6.35M
- Book value
- EGP 1.09B
Growth
- Revenue growth
- 23.52%
- Profit growth
- 54.04%
- EPS growth
- 54.04%
Per share
- EPS (fiscal year)
- 34.77
- Book value per share
- 217.12
- Dividend per share
- 15.5
- Return on equity
- 32.89%
- Return on assets
- 23.26%
Technical
- RSI (14)
- 34.9
- 50-day moving average
- EGP 1,529.4
- 200-day moving average
- EGP 1,112.47
- Beta (1Y)
- 0.04
Shares
- Shares outstanding
- 5M
- Free float
- 29.84%
Fiscal-year figures are as the company last reported them; technical readings refresh with market data.